Our data, which revealed a upregulation of AXIN2, DKK1 and MYC in the TamR cells, are largely consistent with findings documented in current literature on triple negative breast cancer [7,31-36]. This evidence concerns the gene AXIN2 and triple-negative breast carcinoma.